Eva Buck

Heterozygous <i>Tbk1</i> loss has opposing effects in early and late stages of ALS in mice

Dávid Brenner, Kirsten Sieverding, Clara Bruno et al. · The Journal of Experimental Medicine · 2019 · 85 citations · Full text

Contrasting effects of selective MAGL and FAAH inhibition on dopamine depletion and GDNF expression in a chronic MPTP mouse model of Parkinson's disease

Noemi Pasquarelli, Christoph Porazik, Hanna Bayer et al. · Neurochemistry International · 2017 · 49 citations

Dopamine Depletion, Neurophysiology, Medicine +10

ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues

Hanna Bayer, Kerstin Lang, Eva Buck et al. · Neurobiology of Disease · 2016 · 44 citations · Full text

Pgc-1α Expression, Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis +11

Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models

Eva Buck, Hanna Bayer, Katrin S. Lindenberg et al. · Frontiers in Molecular Neuroscience · 2017 · 35 citations · Full text

High-resolution respirometry of fine-needle muscle biopsies in pre-manifest Huntington’s disease expansion mutation carriers shows normal mitochondrial respiratory function

Eva Buck, Martina Zügel, Uwe Schümann et al. · PLoS ONE · 2017 · 16 citations · Full text

Mitochondrial Myopathy, Neurodegenerative Diseases, High-resolution Respirometry +14